Press Releases

Month Year

Month Year

Mar 2, 2023

Sanofi launches R&D Consortium of industry and patient advocacy groups to accelerate medicines development
Feb 28, 2023

Kevzara® (sarilumab) approved by FDA as first and only biologic indicated for patients with polymyalgia rheumatica
Feb 24, 2023

New Phase 3 data presented at WORLDSymposium™ reinforce Nexviazyme® (avalglucosidase alfa-ngpt) as potential new standard of care for all people living with late-onset Pompe disease
Feb 23, 2023

FDA approves once-weekly ALTUVIIIO™, a new class of factor VIII therapy for hemophilia A that offers significant bleed protection
Jan 25, 2023

NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating its potential to transform the treatment landscape for people with hemophilia A

Show per page

Print
Email page
RSS